German specialist agencies to draft medical guidelines:
This article was originally published in Clinica
Executive Summary
The member groups of the German Association of the Scientific Medical Societies (AWMF) are to draw up procedural guidelines for diagnosis and therapy as requested by the Concerted Action in Healthcare. The guidelines will address whether treatment should be on an inpatient or outpatient basis and the doctor's right to prescribe will not be affected. In areas of conflicting specialities the relevant agencies should work together. The AWMF emphasises that specialist groups should only consider medical aspects in drawing up the guidelines.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.